Cutaneous melanoma: From pathogenesis to therapy (Review)

In less than 10 years, melanoma treatment has been revolutionized with the approval of tyrosine kinase inhibitors and immune checkpoint inhibitors, which have been shown to have a significant impact on the prognosis of patients with melanoma. The early steps of this transformation have taken place i...

Descripción completa

Detalles Bibliográficos
Autores principales: Leonardi, Giulia C., Falzone, Luca, Salemi, Rossella, Zanghì, Antonino, Spandidos, Demetrios A., McCubrey, James A., Candido, Saverio, Libra, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843392/
https://www.ncbi.nlm.nih.gov/pubmed/29532857
http://dx.doi.org/10.3892/ijo.2018.4287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843392/
https://www.ncbi.nlm.nih.gov/pubmed/29532857
http://dx.doi.org/10.3892/ijo.2018.4287

Ejemplares similares